Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study.

This retrospective, real-world post-authorization safety study provides reassurance that Saxenda and Victoza are primarily used according to the approved European label, thus their real-world utilization did not raise safety concerns.